Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senators introduce nanotech bill

This article was originally published in The Tan Sheet

Executive Summary

Sens. Mark Pryor, D-Ark., and Benjamin Cardin, D-Md., introduce the Nanotechnology Safety Act of 2010, which tasks FDA with assessing the safety of the technology, the lawmakers announce in a Jan. 21 release. The bill would authorize $25 million annually from 2011 through 2015 to establish an FDA program to assess nanotechnology safety as used in everyday products, and to "develop best practices for companies who employ" nanotechnology, they say. Pryor explains that potential risks must be evaluated and that S. 2942 "will help ensure public safety and confidence in the marketplace," and support firms using the technology
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103738

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel